Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
No universal dose: appropriate use depends on an individuals health profile and is determined by a licensed provider, not a standard number from the internet
M., Kalogjera, L., Vranes, H., Sola, M., Strbe, S., Koprivanac, A., Premuzic Mestrovic, I., & Mestrovic, T
Most experienced users recommend starting at 0.25 mg daily for the first week, then increasing to 0.5 mg daily if well tolerated and additional benefit seems likely
Key benefits Why people compare it 1 Increases intracellular NAD+ approximately 2-fold by blocking NNMT-mediated nicotinamide diversion 2 Activates SIRT1 longevity pathway via NAD+-dependent deacetylase activation 3 Reduces adipocyte size by approximately 40% with decreased DGAT1/DGAT2 expression 4 Produces 7% body weight reduction in DIO mice without appetite suppression 5 Improves glucose tolerance and reduces hepatic steatosis in preclinical obesity models 6 Preserves SAM levels for improved methylation capacity across tissues 7 Orally bioavailable small molecule (173 Da) requiring no injection or reconstitution 8 Shifts adipocyte metabolism from lipid storage to fatty acid oxidation (CPT1A/ACADM upregulation) Deep research About 5-Amino-1MQ 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) with a molecular weight of approximately 173 Da and a CAS registry number of 42675-71-0
When used for insulin, 1 unit equals 1 international unit of insulin because insulin is formulated at 100 IU per mL
Growth hormone and its derivatives have maximum fat-burning effects when insulin is low and glucagon is elevated - which happens during fasting
